This Was A Scheduled Inspection And At The End Of The Inspection, There Were Zero 483s.
Share price of Alembic Pharmaceuticals gained 4 percent intraday Thursday after successful inspection by USFDA.
The United States Food and Drug Administration (USFDA) has conducted an inspection at company's API Facility located at Panelav from December 17 to 19, 2018.
This was a scheduled inspection and at the end of the inspection, there were zero 483s.
At 10:26 hrs Alembic Pharmaceuticals was quoting at Rs 609.90, up Rs 13.10, or 2.20 percent on the BSE.
The share touched its 52-week high Rs 664 and 52-week low Rs 412.40 on 27 September, 2018 and 24 May, 2018, respectively.
Currently, it is trading 8.15 percent below its 52-week high and 47.89 percent above its 52-week low.
TO FREE OF COST FINANCIAL CONSULTATION FROM THE EXPERTS, CLICK ON Stock Option Market Tips OR GIVE ONE MISSED CALL ON 9644405056 TO SUBSCRIBE US!
No comments:
Post a Comment